Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.
Back to BlogSkin Care

Prescription Acne Creams and Gels Compared: Aklief, Epiduo, Aczone, Winlevi, Tretinoin and Clindamycin by the Evidence

S

SafeRxPills Pharmacy Team

Editorial team at SafeRxPills. Articles are written and checked against regulatory drug labelling (DailyMed, FDA, EMA) and published literature.

May 22, 202624 min read
Last updated: October 28, 2026
Share:
In this article (24 sections)

Each medicine with trial results in this guide beat a matching cream or gel without the drug (the "vehicle") in its approval trials. That alone does not tell you much. The useful questions are how big the gain was, which kind of acne each medicine suits, what it does to your skin while it works, which safety rules apply, and which of them you can now buy without a prescription.

This guide answers those questions for the main topical acne medicines: Aklief (trifarotene), Epiduo and Epiduo Forte (adapalene with benzoyl peroxide), Differin (adapalene), tretinoin, Arazlo and Tazorac (tazarotene), Aczone (dapsone), Winlevi (clascoterone), Twyneo, Cabtreo, clindamycin, benzoyl peroxide, salicylic acid and azelaic acid. The backbone is the 2024 American Academy of Dermatology (AAD) acne guideline, followed by the week 12 results printed in each medicine's US prescribing information.

We sell Indian-made packs of several of these medicines (Aklief, Epiduo, dapsone gels, adapalene gels, tretinoin gels, clindamycin gel and azelaic acid), so we have a commercial interest. We do not sell Winlevi. Every number below comes from a source listed at the end, checked on 28 October 2026. This is information, not a prescription: a doctor who can see your skin should choose your treatment.

The short answer

  • Strongly recommended by the AAD in 2024: benzoyl peroxide, topical retinoids (adapalene, tretinoin, tazarotene, trifarotene), topical antibiotics such as clindamycin (but never used alone), and fixed combinations of these.
  • Conditionally recommended: clascoterone (Winlevi), azelaic acid and salicylic acid. Clascoterone's evidence was rated high certainty; the recommendation is conditional because of its current cost.
  • Size of the effect: single-ingredient medicines added 6.5 to 16.6 percentage points of treatment success over their vehicle at week 12. Fixed combinations added 11.7 to 30.0 points. These are separate trials, not a ranking.
  • Over the counter in the US: adapalene 0.1% gel (Differin), adapalene 0.1% with benzoyl peroxide 2.5% (Differin Epiduo, switched on 22 May 2026), benzoyl peroxide 2.5% to 10% and salicylic acid 0.5% to 2%. Everything else here needs a prescription.
  • Safety lines that matter most: tazarotene is contraindicated in pregnancy; dapsone gel can cause methemoglobinemia and is a concern with G6PD deficiency; clascoterone can suppress the adrenal (HPA) axis; all retinoids irritate skin, mostly in the first four weeks.

How to read the numbers in this guide

Acne trials score each patient on a five-point global scale (called IGA, EGSS or GAAS depending on the trial). "Treatment success" in most of the labels used here means reaching "clear" or "almost clear" and improving by at least two grades from the start, usually after 12 weeks. Each trial compares the drug with its own vehicle, the same base cream or gel without the active ingredient. The vehicle is not inert: vehicle success rates in the trials charted here ran from 5.6% to 25.7%.

That is why this guide reports "percentage points above vehicle" rather than raw success rates. Even so, the trials enrolled different patients (some mostly moderate acne, one with half severe), ran in different years and used slightly different scales. The AAD guideline authors state that "available evidence is insufficient to develop a recommendation ... to make recommendations that compare topical BP, retinoids, antibiotics, and their combinations directly against each other." Read the charts as "each one works, by about this much against its own vehicle", not as a league table.

What the 2024 AAD acne guideline recommends

The guideline (Reynolds and colleagues, Journal of the American Academy of Dermatology, 2024) graded 18 recommendations with the GRADE method, which scores two things separately: how strongly the panel recommends a treatment, and how certain the evidence is. The topical part of its recommendation table reads:

Topical treatmentStrength of recommendationCertainty of evidence
Combining treatments with different mechanisms of actionGood practice statementNot graded
Benzoyl peroxideStrongModerate
Topical retinoidsStrongModerate
Topical antibiotics (monotherapy not recommended)StrongModerate
Fixed combination: topical antibiotic with benzoyl peroxideStrongModerate
Fixed combination: topical retinoid with topical antibiotic (use with benzoyl peroxide)StrongModerate
Fixed combination: topical retinoid with benzoyl peroxideStrongModerate
ClascoteroneConditional (because of current cost)High
Azelaic acidConditionalModerate
Salicylic acidConditionalLow

Three points stand out. First, the strongest grades go to the oldest, cheapest ingredients. Second, topical antibiotics earn a strong recommendation only as part of a combination; on their own they are specifically not recommended because of antibiotic resistance. Third, dapsone gel has no separate line in the recommendation table, even though it is FDA-approved for acne. The guideline also pooled three trials and found that a retinoid combined with benzoyl peroxide roughly doubled the chance of treatment success against vehicle (risk ratio 2.19, 95% CI 1.77 to 2.72).

Which medicine for which kind of acne

Acne has several drivers: blocked pores (comedones, the blackheads and whiteheads), the skin bacterium Cutibacterium acnes, inflammation (red papules and pustules) and androgen-driven oil production. Each medicine targets some of these, which is why the AAD's first good practice statement is to combine mechanisms. As a rough guide drawn from how each drug works and what its trials enrolled:

  • Mainly blackheads and whiteheads: a topical retinoid (adapalene, tretinoin, tazarotene or trifarotene), the class aimed at blocked pores.
  • Red bumps and pustules: benzoyl peroxide, a retinoid with benzoyl peroxide, or an antibiotic with benzoyl peroxide. Dapsone gel and clascoterone are prescription alternatives with different mechanisms.
  • Chest, shoulders and back: Aklief's US trials scored acne on the trunk as well as the face, and it beat vehicle on both.
  • Sensitive skin or dark marks after spots: the AAD notes azelaic acid "may be particularly helpful for patients with sensitive skin or darker skin types due to its lightening effect on dyspigmentation."
  • Severe, scarring or treatment-resistant acne: creams and gels are usually not enough. See oral options below.

Single-ingredient medicines against their vehicle

The table and chart below give week 12 success rates for each single-ingredient medicine and its own vehicle, from the trial tables in the US labels. The adapalene 0.1% and benzoyl peroxide 2.5% rows come from the arms of the two Epiduo approval trials that tested each ingredient alone.

MedicineTrial 1: drug vs vehicleTrial 2: drug vs vehicleWho was enrolled
Adapalene 0.1% gel12.2% vs 5.6%19.8% vs 11.3%Moderate facial acne
Benzoyl peroxide 2.5% gel12.1% vs 5.6%22.2% vs 11.3%Moderate facial acne
Dapsone 7.5% gel (Aczone)30% vs 21%30% vs 21%Mostly moderate, age 12 and over, 4,340 patients
Trifarotene 0.005% cream (Aklief), face29.4% vs 19.5%42.3% vs 25.7%Moderate face and trunk acne, age 9 and over
Clascoterone 1% cream (Winlevi)18.8% vs 8.7%20.9% vs 6.6%Moderate or severe facial acne, age 12 and over
Adapalene 0.3% gel (Differin)21% vs 9% (one trial; clear or almost clear only)Not applicableMild to moderate, age 12 to 52
Tazarotene 0.045% lotion (Arazlo)25.5% vs 13%29.6% vs 17.3%Moderate or severe facial acne, age 9 and over
Grouped bar chart of percentage points above vehicle in week 12 treatment success, trial 1 then trial 2. Adapalene 0.1%: 6.6 and 8.5. Benzoyl peroxide 2.5%: 6.5 and 10.9. Dapsone 7.5% (Aczone): 9 and 9. Trifarotene 0.005% (Aklief): 9.9 and 16.6. Clascoterone 1% (Winlevi): 10.1 and 14.3. Adapalene 0.3% (Differin, one trial): 12. Tazarotene 0.045% (Arazlo): 12.5 and 12.3.
Figure 1. How far each single-ingredient medicine beat its own vehicle (the same cream or gel without the drug) in its US approval trials. The trials differed in patients and scoring, so the bars are not a ranking. Source: US labels listed under the chart.

The gains cluster between about 7 and 17 points. Put another way, for every 100 people treated for 12 weeks, roughly 7 to 17 more reached clear or almost clear skin than on the vehicle. Lesion counts tell the same story: on Aklief, inflammatory lesions on the face fell by 54.4% and 66.2% in the two trials against 44.8% and 51.2% on vehicle.

Combination gels against their vehicle

Fixed combinations put two or three ingredients in one tube. Their gains over vehicle were larger, in line with the AAD's advice to combine mechanisms.

CombinationTrial 1: drug vs vehicleTrial 2: drug vs vehicleWho was enrolled
Adapalene 0.1% + benzoyl peroxide 2.5% (Epiduo)21.5% vs 5.6%30.1% vs 11.3%Moderate facial acne
Tretinoin 0.1% + benzoyl peroxide 3% (Twyneo)39.9% vs 14.3%26.8% vs 15.1%Moderate or severe facial acne, age 9 and over
Adapalene 0.3% + benzoyl peroxide 2.5% (Epiduo Forte)33.7% vs 11.0% (one trial)Not applicableHalf moderate, half severe
Clindamycin 1.2% + adapalene 0.15% + benzoyl peroxide 3.1% (Cabtreo)49.6% vs 24.9%50.5% vs 20.5%Moderate or severe facial acne, 363 patients
Grouped bar chart of percentage points above vehicle in week 12 treatment success, trial 1 then trial 2. Adapalene 0.1% with benzoyl peroxide 2.5% (Epiduo): 15.9 and 18.8. Tretinoin 0.1% with benzoyl peroxide 3% (Twyneo): 25.6 and 11.7. Adapalene 0.3% with benzoyl peroxide 2.5% (Epiduo Forte, one trial): 22.7. Clindamycin, adapalene and benzoyl peroxide (Cabtreo): 24.7 and 30.0.
Figure 2. How far each fixed-dose combination beat its own vehicle in its US approval trials. The current DailyMed version of Twyneo's label prints 33.9% for trial 1, but the FDA-approved 2021 label and the Health Canada monograph print 39.9%, which matches the label's stated 25.7-point difference; we use 39.9%. Source: US labels listed under the chart.

Cabtreo, the only triple combination in this guide, posted the largest single gain (30.0 points in trial 2); its trial 1 gain (24.7) was similar to Twyneo's trial 1 gain (25.6). Cabtreo's two trials were small (363 patients in total) and required 30 to 100 inflammatory lesions at entry, more than most of the other trials.

Why combinations win: one trial that tested both

The cleanest evidence for combining comes from the second Epiduo approval trial, where 1,668 people with moderate facial acne were randomised to the combination, adapalene alone, benzoyl peroxide alone or vehicle. Because everyone was in the same trial, this is a fair head-to-head comparison.

Arm (Study 2, week 12)PatientsTreatment successInflammatory lesions, mean reduction
Vehicle gel41811.3%30.2%
Adapalene 0.1% alone42019.8%41.7%
Benzoyl peroxide 2.5% alone41522.2%47.6%
Adapalene 0.1% + benzoyl peroxide 2.5%41530.1%53.4%
Bar chart from one trial of 1,668 patients at week 12: vehicle gel 11.3% treatment success, adapalene 0.1% alone 19.8%, benzoyl peroxide 2.5% alone 22.2%, adapalene 0.1% with benzoyl peroxide 2.5% 30.1%.
Figure 3. The only trial in this guide that compared a combination with each of its ingredients alone: the same trial gave patients the combination, each ingredient alone, or vehicle. Source: adapalene and benzoyl peroxide gel 0.1%/2.5% US label, Study 2.

The label adds that in both main trials, the treatment effect was smaller in people who started with few lesions. If your acne is mild, expect a smaller visible difference from any of these products.

Aklief (trifarotene 0.005% cream)

Aklief was approved by the FDA on 4 October 2019 as a new molecular entity. It is a cream applied once daily in the evening. The label says one pump should cover the face and two pumps the upper trunk, and recommends a moisturiser from the start.

Its two approval trials enrolled 2,420 people aged 9 and over with moderate acne on both the face and trunk. On the trunk, success reached 35.7% and 42.6% against 25.0% and 29.9% on vehicle. Application site irritation was reported by 7.5% of Aklief users against 0.3% on vehicle, and the label notes that erythema, scaling, dryness and stinging peak within the first 4 weeks. Aklief has no contraindications on its US label. Read more in our guide to retinoid strengths compared.

Epiduo and Epiduo Forte (adapalene with benzoyl peroxide)

Epiduo combines adapalene 0.1% with benzoyl peroxide 2.5%; Epiduo Forte raises the adapalene to 0.3%. Both are applied once daily as a thin layer, about a pea-sized amount for each area of the face.

The status of the original strength changed this year. On 22 May 2026 the FDA approved Galderma's partial prescription-to-OTC switch (NDA 220736), and it is now sold as Differin Epiduo Acne Gel for people 12 and over. The original prescription Epiduo application is listed as discontinued in Drugs@FDA, while prescription generic versions of the 0.1%/2.5% gel remain on DailyMed. Epiduo Forte is still prescription only.

Epiduo Forte's single approval trial enrolled 503 people, half with severe acne, and reported 33.7% success against 11.0% on vehicle. The trial also included an Epiduo 0.1%/2.5% arm (27.3% success), but the label states the trial was not designed or powered to compare the two strengths, so do not read the 6.4-point gap as proof that Forte is better. Epiduo Forte is contraindicated in people with a history of hypersensitivity reactions to benzoyl peroxide, and its label warns that anaphylaxis, angioedema and urticaria have been reported with benzoyl peroxide products. Twyneo and Cabtreo carry the same contraindication for benzoyl peroxide hypersensitivity. Benzoyl peroxide can also bleach hair and coloured fabrics.

Differin and other adapalene gels

Adapalene 0.1% gel has been sold over the counter in the US as Differin since the FDA approved the switch on 8 July 2016. Its Drug Facts label covers adults and children 12 and over, once daily. The 0.3% gel remains a prescription product. In its one approval trial (653 people aged 12 to 52), success at week 12 was 21% on 0.3%, 16% on 0.1% and 9% on vehicle.

For how adapalene compares with tretinoin in direct trials, see adapalene vs tretinoin.

Tretinoin gels and creams

Tretinoin is prescription only in the US. The Retin-A Micro label reports lesion counts and an investigator rating rather than the "clear or almost clear" endpoint, so its trials are not directly comparable with the newer drugs above. Retin-A Micro 0.1% gel cut total lesion counts by 45% and 32% at week 12 against 23% and 16% on vehicle, and 35% and 28% of users were rated "excellent" by investigators against 11% and 9% on vehicle. The lower 0.04% strength also beat vehicle in two trials.

Twyneo pairs tretinoin 0.1% with benzoyl peroxide 3% in one cream (results above). Application site pain (stinging, burning) was reported by 10.6% of Twyneo users against 0.4% on vehicle. For application technique and how the early flare works, see how to use tretinoin and the tretinoin purge. For tretinoin prices, our buy tretinoin online guide covers costs in detail.

Tazarotene (Arazlo and Tazorac): the pregnancy rule

Tazarotene carries the strictest pregnancy rule of the topical retinoids. Arazlo 0.045% lotion is approved for acne from age 9; Tazorac 0.1% cream is approved for acne, and Tazorac 0.1% gel for mild to moderate facial acne. Arazlo beat vehicle by 12.5 and 12.3 points. In the Tazorac cream acne trials, 18% and 20% had no or minimal acne at week 12 against 11% and 6% on vehicle.

Both labels state that tazarotene is contraindicated in pregnancy because it may cause fetal harm. Arazlo's label adds three instructions: obtain a pregnancy test within 2 weeks before starting, start treatment during a menstrual period, and use effective contraception during treatment. Tazorac's label also lists hypersensitivity to any component as a contraindication. Arazlo's label says to avoid using it with benzoyl peroxide or other oxidising agents; if both are needed, apply one in the morning and the other in the evening.

Dapsone gel (Aczone 7.5% and generic 5%)

Dapsone is also used as an oral medicine, and the acne gel carries warnings drawn from oral use; its label states that how the gel works in acne is not known. The 7.5% gel (Aczone) is applied once daily from age 9; the 5% gel (also sold as generics) is applied twice daily. In the 7.5% trials of 4,340 people, success was 30% against 21% on vehicle in both trials. In the 5% trials, 42% and 35% had no or minimal acne against 32% and 28% on vehicle (a looser endpoint without the 2-grade requirement). If there is no improvement after 12 weeks, both labels say treatment should be reassessed.

Dapsone gel has no contraindications, but its warnings are specific:

  • Methemoglobinemia: cases with hospitalisation were reported with twice daily dapsone gel 5%. Avoid it with congenital or idiopathic methemoglobinemia. A slate grey colour of the lips, mouth lining or nail beds is a reason to stop and seek immediate medical attention.
  • G6PD deficiency: people with G6PD deficiency may be more prone to methemoglobinemia and hemolysis. In a study of 64 people with G6PD deficiency using the 5% gel, some developed laboratory changes suggesting hemolysis, without clinically significant hemolytic anemia.
  • Other medicines: avoid use with oral dapsone or antimalarials, and take care with trimethoprim/sulfamethoxazole.
  • With benzoyl peroxide: applying dapsone gel then benzoyl peroxide can temporarily turn skin and facial hair yellow or orange.

Dapsone was gentle in its trials: application site dryness affected 1.1% of Aczone users against 1.0% on vehicle.

Winlevi (clascoterone 1% cream)

Winlevi, approved on 26 August 2020 as a new molecular entity, contains clascoterone, an androgen receptor inhibitor. None of the other creams here works on androgen receptors, although the label says the exact way Winlevi treats acne is unknown. It is applied twice daily from age 12, and its trials included both sexes (38% male).

In two trials of 1,421 people aged 12 and over, success reached 18.8% and 20.9% against 8.7% and 6.6% on vehicle, and local skin reactions were similar to vehicle (for example, redness in 12.2% against 15.4%). The AAD rated its evidence as high certainty but gave only a conditional recommendation because of cost.

The key warning is HPA axis suppression, which means the cream can reduce the body's own cortisol response. In a 2-week study, it occurred in 1 of 20 adults (5%) and 2 of 22 adolescents (9%); all returned to normal 4 weeks after stopping. Large treated areas, long use and occlusive dressings increase absorption. Raised potassium was seen in 5% of users against 4% on vehicle. We do not sell Winlevi, and Drugs@FDA lists no approved generic clascoterone.

Clindamycin and other topical antibiotics

Clindamycin 1% gel or lotion is an antibiotic aimed at C. acnes, but the AAD says topical antibiotics should not be used alone, and recommends benzoyl peroxide alongside them to prevent antibiotic resistance. Fixed combinations of clindamycin with benzoyl peroxide carry a strong AAD recommendation. In the Onexton trial (clindamycin 1.2% with benzoyl peroxide 3.75%), 29% were clear or almost clear at week 12 against 15% on vehicle, and inflammatory lesions fell by 60.4% against 31.3%.

Topical clindamycin, including plain clindamycin 1% gel (Cleocin T) and the combinations Onexton and Cabtreo, is contraindicated in people with a history of regional enteritis, ulcerative colitis or antibiotic-associated colitis, and in those with hypersensitivity to clindamycin or lincomycin. Diarrhoea, bloody diarrhoea and colitis have been reported with topical clindamycin; the Onexton label says to stop the gel if significant diarrhoea occurs. Our topical antibiotics for acne guide covers clindamycin and erythromycin gels in detail.

Benzoyl peroxide, salicylic acid and azelaic acid

Benzoyl peroxide carries a strong AAD recommendation and is sold without a prescription at 2.5% to 10% under the FDA's acne monograph. In the Epiduo trials, 2.5% alone beat vehicle by 6.5 and 10.9 points. It can bleach towels, pillowcases and hair.

Salicylic acid 0.5% to 2% is also an OTC monograph ingredient. The AAD gives it only a conditional recommendation based on low certainty evidence.

Azelaic acid has a conditional AAD recommendation with moderate certainty evidence. The US Azelex label approves the 20% cream for mild to moderate inflammatory acne. The AAD's note on sensitive skin and dark marks is quoted above. See our azelaic acid cream guide.

What is over the counter in the US in 2026

Ingredient and strengthUS statusLabel age
Adapalene 0.1% gel (Differin)Over the counter since 8 July 201612 and over; under 12, ask a doctor
Adapalene 0.1% + benzoyl peroxide 2.5% (Differin Epiduo)Over the counter since 22 May 202612 and over; under 12, do not use
Benzoyl peroxide 2.5% to 10%OTC acne monographSee product label
Salicylic acid 0.5% to 2%OTC acne monographSee product label
Adapalene 0.3%, Epiduo Forte, tretinoin, tazarotene, trifarotene, dapsone, clascoterone, clindamycin and their combinationsPrescription onlySee each label

The OTC Differin Epiduo label warns to stop and ask a doctor if you become pregnant or plan to, and if there is no improvement after 3 months of once daily use.

Side effects compared

Irritation is the main trade-off with retinoids and benzoyl peroxide. The labels report it in different ways, so the table lists a headline application-site reaction from each label.

MedicineReaction (label term)DrugVehicle
AkliefApplication site irritation7.5%0.3%
ArazloApplication site pain (stinging, burning or pain)5%under 1%
TwyneoApplication site pain10.6%0.4%
CabtreoApplication site pain (including stinging and burning)13.6%0.8%
Epiduo ForteSkin irritation4%0%
Aczone 7.5%Application site dryness1.1%1.0%
WinleviRedness (local skin reaction, reported less often than on vehicle)12.2%15.4%

Most retinoid labels say irritation peaks in the first 4 weeks and settles with continued use. The label fixes are a moisturiser, applying less often for a while, and avoiding waxing, harsh cleansers and astringents on treated skin. Retinoid labels warn about sun sensitivity and recommend sunscreen and protective clothing over treated skin.

Pregnancy and breastfeeding

According to the AAD guideline, topical therapies other than retinoids are preferred during pregnancy. What each label says:

  • Tazarotene (Arazlo, Tazorac): contraindicated in pregnancy.
  • Trifarotene (Aklief): data from pregnant women in clinical trials have not identified a drug-associated risk; oral doses in animals at more than 800 times human exposure caused fetal harm.
  • Adapalene: the OTC labels say to ask a doctor before use if pregnant or breastfeeding, and to stop and ask a doctor if you become pregnant.
  • Topical tretinoin: decades of observational studies have not established a drug-associated risk of birth defects.
  • Dapsone 7.5% and clascoterone: no available data in pregnant women; clascoterone caused malformations in rats at 8 times the maximum human dose.

If you are pregnant, planning a pregnancy or breastfeeding, discuss acne treatment with your doctor before starting or continuing any of these.

When creams and gels are not enough

The AAD strongly recommends oral doxycycline, with two good practice statements attached: limit systemic antibiotics where possible, and use them together with benzoyl peroxide and other topicals. Isotretinoin is the treatment for severe acne, acne causing scarring or psychosocial burden, and acne that has failed standard oral or topical therapy. See doxycycline for acne and isotretinoin for acne.

If your concern is melasma or dark patches rather than acne, that is a different set of medicines, covered in our hydroquinone cream guide and skin lightening creams compared.

Acne creams and gels we sell

These are Indian-made packs. They are not FDA-approved products and are not registered with US regulators. Prices are from our catalogue as of 28 October 2026 for the smallest pack of each product.

ProductActive ingredientSmallest packPricePer tube
Aklief 30 gTrifarotene 0.005%1 tube$58.00$58.00
Epiduo GelAdapalene 0.1% + benzoyl peroxide 2.5%1 tube$25.00$25.00
Acnedap 15 gDapsone 5%1 tube$21.00$21.00
Acnewar 15 gDapsone + adapalene (check strengths on the carton)3 tubes$33.00$11.00
Adaferin 15 gAdapalene (check strength on the carton)3 tubes$30.00$10.00
Adapen 15 gAdapalene (check strength on the carton)3 tubes$27.50$9.17
A Ret Gel 0.025%Tretinoin 0.025%3 tubes$18.00$6.00
A Ret Gel 0.05%Tretinoin 0.05%3 tubes$19.50$6.50
A Ret Gel 0.1%Tretinoin 0.1%3 tubes$25.50$8.50
Erytop GelClindamycin 1%3 tubes$16.25$5.42
Persol AC 5% GelBenzoyl peroxide 5%3 tubes$20.00$6.67
Aziderm Gel 20%Azelaic acid 20%3 tubes$28.75$9.58

Acnedap is dapsone 5%; the US label for dapsone 5% gel uses twice daily application, unlike once daily Aczone 7.5%. On importing medicines, the FDA's personal importation page states: "In most circumstances, it is illegal for individuals to import drugs or devices into the U.S. for personal use because these products purchased from other countries often have not been approved by the FDA for use and sale in the U.S." Read the FDA personal importation page and check your own situation before ordering. For the different ways to get acne treatment in the US and what each costs, see acne treatment online.

Questions to ask your doctor

  • Is my acne mainly comedonal, inflammatory or both, and which medicine fits that?
  • Should I start with a combination product rather than one ingredient?
  • If you prescribe clindamycin, which benzoyl peroxide product should I use with it?
  • Do I need a G6PD test before dapsone gel?
  • I may become pregnant. Which options are safest for me?
  • How long should I give this before we judge it, and what is the next step if it fails?

Sources

  1. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2024;90(5):1006.e1-1006.e30. PMID 38300170. Recommendation table as reproduced in the Oregon Drug Use Review acne class update (April 2026, Table 5) and the Medscape guideline summary; guideline quotations as reported by MDedge.
  2. AKLIEF (trifarotene) cream 0.005%, US prescribing information, Galderma, 9/2024 (DailyMed setid 62d910db-85a6-4696-b69b-4bd2f3080cfc): sections 1 to 6, 8.1, 14.
  3. ACZONE (dapsone) gel 7.5%, US prescribing information, Almirall, 10/2025 (setid 22058b7d-a578-4eaa-a476-ac982337f02a): sections 1 to 8.6, 14.
  4. Dapsone gel 5%, US prescribing information, Encube Ethicals, 10/2025 (setid 4205a1a9-c459-47bb-9538-1dd559ca71f1): sections 2, 14.
  5. WINLEVI (clascoterone) cream 1%, US prescribing information, Sun Pharmaceutical Industries, 1/2025 (setid 1673a84b-7f5c-47ab-a99c-1e3db21a6a09): sections 1 to 6.1, 8, 12.2, 14.
  6. Adapalene and benzoyl peroxide gel 0.1%/2.5%, US prescribing information, Encube Ethicals, 6/2026 (setid 66858a82-cfda-4ba9-aac7-cf65499f4b1a): section 14, Table 3.
  7. EPIDUO FORTE (adapalene and benzoyl peroxide) gel 0.3%/2.5%, US prescribing information, Galderma, 10/2024 (setid f4e5d381-098a-4c93-9ff0-002cae46daac): sections 1 to 6.1, 8.1, 14.
  8. DIFFERIN EPIDUO acne gel, OTC Drug Facts, Galderma, 5/2026 (setid ae3f8cd9-9046-4b69-b80f-3e9d4468ba7f); Drugs@FDA NDA 220736 (approved 22 May 2026, partial Rx to OTC switch) and NDA 022320.
  9. DIFFERIN (adapalene) gel 0.3%, US prescribing information, Galderma, 12/2023 (setid a0031324-92a6-4c11-90e2-c2818f7278ec): section 14; DIFFERIN gel 0.1% OTC Drug Facts (setid 0739d631-171b-42a8-bd55-0022b8df2d8a); Drugs@FDA NDA 020380 (supplement approved 8 July 2016).
  10. ARAZLO (tazarotene) lotion 0.045%, US prescribing information, Bausch Health, 9/2023 (setid d941ff25-c221-4a55-8012-0dcf3bbcbbd1): sections 2, 4, 5, 6.1, 14.
  11. TAZORAC (tazarotene) cream and gel, US prescribing information, Almirall, 11/2025 (setids 021744d1-a6d7-4ad6-99c2-7187c24e64c6 and 4e4e4b81-420e-4492-8a74-80b692a80057): sections 1, 4, 14.
  12. TWYNEO (tretinoin and benzoyl peroxide) cream 0.1%/3%, US prescribing information, Galderma, 5/2025 (setid 27208dff-e376-4c18-b56e-0a260f685a39): sections 1, 3, 4, 6.1, 8.1, 14.
  13. TWYNEO (tretinoin and benzoyl peroxide) cream, FDA-approved US prescribing information, 2021, NDA 214902 (accessdata.fda.gov 214902s000lbl.pdf): section 14, trial 1 IGA success 39.9% vs 14.3%.
  14. CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) gel, US prescribing information, Bausch Health, 4/2025 (setid 9468da0f-9978-4c58-8135-0274c3415084): sections 1, 3, 4, 6.1, 14.
  15. RETIN-A MICRO (tretinoin) gel, US prescribing information, Bausch Health, 9/2025 (setid 08ab7e0c-1437-455f-815c-98904d96a289): sections 8.1, 14.
  16. ONEXTON (clindamycin phosphate and benzoyl peroxide) gel 1.2%/3.75%, US prescribing information, Bausch Health, 7/2025 (setid 697e760a-c206-4565-8f4e-a8085e215827): sections 1, 4, 14.
  17. CLEOCIN T (clindamycin phosphate) topical solution, gel and lotion, US prescribing information, Pfizer, revised 11/2025 (setid 4a3901a4-194f-4a15-9c85-3d0982afcf31): indications, contraindications.
  18. AZELEX (azelaic acid) cream 20%, US prescribing information, Almirall, 3/2024 (setid ebdfcaf7-b5d6-47e1-be87-ccaba4b97e75): indications and contraindications.
  19. US Code of Federal Regulations, 21 CFR 333.310, acne active ingredients (eCFR, accessed 28 October 2026).
  20. US Food and Drug Administration. Drugs@FDA via openFDA: NDA 211527 (Aklief), NDA 207154 (Aczone), NDA 213433 (Winlevi; the only clascoterone application listed), accessed 28 October 2026.
  21. US Food and Drug Administration. Personal importation, accessed 28 October 2026.

This guide is for information and does not replace advice from a doctor or pharmacist who knows your medical history.

?Frequently Asked Questions

What is the strongest prescription acne cream?

There is no fair ranking, because each cream was tested against its own vehicle in separate trials, and the 2024 AAD guideline says the evidence is insufficient to compare benzoyl peroxide, retinoids, antibiotics and their combinations directly. In their US approval trials, fixed combinations gained the most over vehicle: Cabtreo (clindamycin, adapalene and benzoyl peroxide) by 24.7 and 30.0 percentage points, Epiduo Forte by 22.7. Single ingredients gained 6.5 to 16.6 points.

Is Aklief better than Epiduo?

They have not been compared head to head in their US labels. Aklief (trifarotene 0.005%) beat its vehicle by 9.9 and 16.6 points on the face and was also tested on the chest and back. Epiduo (adapalene 0.1% with benzoyl peroxide 2.5%) beat its vehicle by 15.9 and 18.8 points. Epiduo combines two mechanisms, which the AAD recommends; Aklief can be paired with a separate benzoyl peroxide product.

Is Epiduo available over the counter in the US?

Yes, the original strength is. On 22 May 2026 the FDA approved a partial prescription-to-OTC switch, and adapalene 0.1% with benzoyl peroxide 2.5% is now sold as Differin Epiduo Acne Gel for people 12 and over. Epiduo Forte (adapalene 0.3% with benzoyl peroxide 2.5%) remains prescription only.

How well does Winlevi work?

In two 12-week trials of 1,421 people aged 12 and over, 18.8% and 20.9% reached clear or almost clear skin with a 2-grade improvement, against 8.7% and 6.6% on vehicle. The AAD rated the evidence high certainty but recommends clascoterone only conditionally because of its cost. Its main warning is suppression of the adrenal (HPA) axis. We do not sell Winlevi.

Who should not use dapsone gel (Aczone)?

Aczone has no listed contraindications, but its label says to avoid it in people with congenital or idiopathic methemoglobinemia and in people taking oral dapsone or antimalarial medicines. People with G6PD deficiency may be more prone to methemoglobinemia and hemolysis. Stop and get urgent care if the lips, mouth lining or nail beds turn slate grey.

Can I use tazarotene if I might get pregnant?

Tazarotene (Arazlo, Tazorac) is contraindicated in pregnancy. The Arazlo label says to obtain a pregnancy test within 2 weeks before starting, begin treatment during a menstrual period and use effective contraception during treatment. Discuss alternatives with your doctor if you could become pregnant.

Can I use clindamycin gel on its own for acne?

The 2024 AAD guideline strongly recommends topical antibiotics but specifically does not recommend using them alone, because of antibiotic resistance. It recommends benzoyl peroxide alongside them, and fixed combinations of clindamycin with benzoyl peroxide or with a retinoid carry strong recommendations.

Which acne medicines can I buy without a prescription in the US?

Adapalene 0.1% gel (Differin), adapalene 0.1% with benzoyl peroxide 2.5% (Differin Epiduo, since 22 May 2026), benzoyl peroxide 2.5% to 10% and salicylic acid 0.5% to 2%. Adapalene 0.3%, Epiduo Forte, tretinoin, tazarotene, trifarotene, dapsone, clascoterone and clindamycin products need a prescription.

How long do prescription acne creams take to work?

The approval trials judged results at 12 weeks. The Aczone and dapsone 5% labels say treatment should be reassessed if there is no improvement after 12 weeks, and the OTC Differin Epiduo label says to ask a doctor if there is no improvement after 3 months of once daily use. Retinoid irritation is usually worst in the first 4 weeks.

Do these creams cause irritation?

Retinoids and benzoyl peroxide often do, mostly early on. Application site irritation was reported by 7.5% of Aklief users against 0.3% on vehicle, and application site pain by 10.6% on Twyneo and 13.6% on Cabtreo against under 1% on vehicle. Aczone dryness (1.1% against 1.0%) and Winlevi skin reactions were close to vehicle. The labels' first steps are a moisturiser and applying less often.

Can I use benzoyl peroxide with dapsone gel?

Yes, but the Aczone label notes that applying dapsone gel and then benzoyl peroxide can temporarily turn the skin and facial hair yellow or orange. Benzoyl peroxide can also bleach hair, towels and coloured fabrics, so wash your hands after applying it.

S

SafeRxPills Pharmacy Team

SafeRxPills Editorial Team

Editorial team at SafeRxPills. Articles are written and checked against regulatory drug labelling (DailyMed, FDA, EMA) and published literature.

Comments (0)

Leave a Comment

No comments yet. Be the first to share your thoughts!